- Constellation Software‘s first-quarter revenue was $2.65 billion.
- Analysts had estimated revenue to be higher at $2.76 billion.
- The company’s earnings per share (EPS) for this quarter was $5.44.
- This EPS figure fell short of analyst estimates, which were $9.29.
- Currently, 9 analysts recommend buying the company’s stock.
- 2 analysts suggest holding on to shares.
- 1 analyst has given a sell recommendation.
A look at Constellation Software Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Constellation Software Inc, a software holding company known for acquiring and nurturing mission-critical, vertical market software firms, is forecasted to have a positive long-term trajectory. According to Smartkarma Smart Scores, the company shows strength in growth and momentum aspects, with scores of 4 in each category. This indicates a favorable outlook for expansion and market performance. While the value and dividend scores are moderate at 2, showing room for improvement in these areas, Constellation Software‘s resilience score of 3 suggests a decent ability to weather uncertainties and challenges in the market.
In summary, Constellation Software‘s future seems promising, especially in terms of growth opportunities and market momentum. With a focus on acquiring and nurturing specialized software companies, the company’s strategic approach aligns well with its strong growth and momentum scores, positioning it for potential success in the long run despite some room for improvement in value and dividends.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
